Intravenous iron supplementation in children on hemodialysis

Journal of Nephrology

Volumn 17, Issue 3, 2004, Pages 423-426

  Leijn, Eveline ^a   Monnens, Leo A H ^a   Cornelissen, Elisabeth A M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Children; Erythropoietin; Hemodialysis; Hydroxysaccharate; Intravenous; Intravenous iron; Iron; Iron deficiency; Iron hydroxide sucrose complex

Indexed keywords

CYANOCOBALAMIN; FERRITIN; FOLIC ACID; IRON COMPLEX; MULTIVITAMIN; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON OVERLOAD; IRON THERAPY; KIDNEY FAILURE; MAINTENANCE THERAPY; MALE; OUTCOMES RESEARCH; PROSPECTIVE STUDY; TRANSFERRIN BLOOD LEVEL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FERRIC COMPOUNDS; FERRITINS; HUMANS; INJECTIONS, INTRAVENOUS; IRON; KIDNEY FAILURE, CHRONIC; MALE; RENAL DIALYSIS; TRANSFERRIN;

EID: 4243198306     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Drüeke TB, Bárány P, Cazzola M. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients. Clin Nephrol 1997; 48: 1-8.
2. Schaefer RM, Bahner U. Iron metabolism in rhEPO-treated hemodialysis patients. Clin Nephrol 2000; 53 (suppl): S65-8.
3. Goudnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 2000; 96: 823-33.
4. Hörl WH, Cavill I, MacDougall IC, Schaefer RM, Sunder-Plassmann G. How to diagnose and correct iron deficiency during r-huEPO therapy - a consensus report. Nephrol Dial Transplant 1996; 11: 246-50.
5. Kooistra MP, Niemantsverdriet EC, Van Es A, Mol-Beermann NM, Struyvenberg A, Marx JJ. Iron absorption in erythropoietin-treated haemodialysis patients: effects of iron availability, inflammation and aluminium. Nephrol Dial Transplant 1998; 13: 82-8.
6. Sunder-Plassmann G, Hörl WH. Importance of iron supply for erythropoietin therapy. Nephrol Dial Transplant 1995; 10: 2070-6.
7. Morgan HE, Gautam M, Geary DF. Maintenance intravenous iron therapy in pediatric hemodialysis patients. Pediatr Nephrol 2001; 116: 779-83.
8. Van Damme-Lombaerts R, Herman J. Erythropoietin treatment in children with renal failure. Pediatr Nephrol 1999; 13: 148-52.
9. Yee J, Besarab A. Iron sucrose: The oldest iron therapy becomes new. Am J Kidney Dis 2002; 40: 1111-21.
10. Bailie GR, Johnson CA, Mason NA. Parenteral iron use in the management of anemia in end-stage renal disease patients. Am J Kidney Dis 2000; 35: 1-12.
11. Nephrology Self-Assessment Program. Management of anemia in dialysis patients 2002; 1: 99-102.
12. Fishbane S, Frei GL, Maesaka J. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. Am J Kidney Dis 1995; 26: 41-6.
13. Silverberg DS, Blum M, Peer G, Kaplan E, Iaina A. Intravenous ferric saccharate as an iron supplement in dialysis patients. Nephron 1996; 72: 413-7.
14. Fishbane S, Maesaka JK. Iron management in end-stage renal disease. Am J Kidney Dis 1997; 29: 319-33.
15. Hörl WH. How to get the best out of r-HuEPO. Nephrol Dial Transplant 1995; 10 (suppl 2): S92-5.
16. Sunder-Plassmann G, Hörl WH. Erythropoietin and iron. Clin Nephrol 1997; 47: 141-57.
17. Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure. Nephrol Dial Transplant 1999; 14 (suppl 5): S1-50.
18. Sunder-Plassmann G, Spitzauer S, Hörl WH. The dilemma of evaluating iron status in dialysis patients - limitations of available diagnostic procedures. Nephrol Dial Transplant 1997; 12: 1575-80.